… Smith and Amnesty International UK ASTRAZENECA AstraZeneca has placed Wang on “ … , the chief executive of Amnesty International UK. Deshmukh said: “AstraZeneca’s decision … . Sir Pascal Soriot, AstraZeneca’s group chief executive, has previously spoken about …

… BP, pharmaceutical heavyweight AstraZeneca and Formula One’ … costs and boost performance. AstraZeneca: personalised medicine   … Following BP’s presentation, AstraZeneca’s chief digital officer … increasingly crucial. Christian Horner, CEO, Red Bull Racing   …

… for alleged medical insurance fraud. AstraZeneca placed Wang on “extended leave … can see.” Sacha Deshmukh, the chief executive of Amnesty International UK, said … the import of medicines ASTRAZENECA He added: “AstraZeneca’s decision to continue …

AstraZeneca’s rare disease business, Alexion, … ’s Azure. Pangaea founder and CEO Dr Vibhor Gupta said: “The … Alexion Pharmaceuticals became part of AstraZeneca following an acquisition in 2020 …

… on for a new chief executive at WPP after Mark … . Devika Bulchandani, Ogilvy Global CEO Devika Bulchandani. Taylor Hill… like Ford, Microsoft, and AstraZeneca. WPP last year said VML … in May. Johnny Hornby, CEO, WPP specialist communications agency division …

… driving transformative business growth at AstraZeneca, including leading the launch of … been recognised with several AstraZeneca Excellence and CEO Awards. As an Oncology … is headquartered at Bengaluru, Karnataka. AstraZeneca Pharma India Limited is the …

… with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases … ," Vibhor Gupta, founder and CEO of Pangea Data, told MobiHealthNews …

… , home to major institutions including AstraZeneca, GSK, and Addenbrooke’s Hospital … 's growth potential,” said chief executive officer Neil Crabb. “We anticipate …

… in the oncology division at AstraZeneca. “While the findings need to … of cancer,” Cancer Research UK chief executive Michelle Mitchell said. “Further studies …

… field," said Dario Neri, chief executive and chief scientific officer of … , with Novartis, BMS, Eli Lilly, AstraZeneca, and Bayer all building a …